Investment
Features
FeesSafety
Academy
More
Pluang+

AMC CEO questions Robinhood's claim that stock tokens are backed 1:1 by shares, citing possible lending to short sellers.

Market News
13 Sep 2026
Crypto news
View Source
Bearish
AMC CEO questions Robinhood's claim that stock tokens are backed 1:1 by shares, citing possible lending to short sellers.

AMC Entertainment CEO Adam Aron challenged Robinhood's claim that its stock tokens are backed one-for-one by actual shares, questioning if those shares could be lent to short sellers, which would undermine the backing. Robinhood's tokens provide economic exposure but no shareholder voting rights, and are issued offshore, unavailable to U.S. customers. Aron called the token model "abhorrent" and raised concerns about investor misunderstanding and regulatory issues. Robinhood has not publicly answered whether shares backing tokens are lent out, leaving questions about the true nature of the backing and voting rights unresolved.

More News

XRP struggles below $1.40 as ETF launches delay and network activity drops sharply.

XRP struggles below $1.40 as ETF launches delay and network activity drops sharply.

XRP remains stuck in a narrow trading range between $1.35 and $1.37, unable to break the key $1.40 resistance level. The launch of Roundhill’s XRP Covered Call ETF and Teucrium’s 2x Short Daily XRP ETF has been postponed to October 11, 2026, reflecti...

Market News
Neutral
4 hours ago
Solana founder claims Musk and Altman's AI slowdown is driven by profit motives at $1 trillion valuation

Solana founder claims Musk and Altman's AI slowdown is driven by profit motives at $1 trillion valuation

Anatoly Yakovenko, co-founder of Solana, criticized Elon Musk and Sam Altman's recent call to slow AI development, suggesting their concern is driven by financial motives to protect their companies' $1 trillion market valuations. He argues that risin...

Market News
Bearish
4 hours ago
Kardigan targets genetic heart and valve diseases with $660.7M cash, eyeing key 2027 clinical data.

Kardigan targets genetic heart and valve diseases with $660.7M cash, eyeing key 2027 clinical data.

Kardigan is focusing on three patient groups: genetic dilated cardiomyopathy, moderate calcific aortic valve stenosis, and post-hospitalization acute severe hypertension. The company holds $660.7 million in liquid assets, providing a runway of about ...

Analyst Insights
Bullish
4 hours ago
NuScale Power CFO sells 20,000 shares amid 74% stock drop in past year

NuScale Power CFO sells 20,000 shares amid 74% stock drop in past year

NuScale Power's Chief Financial Officer sold 20,000 shares of the company as its stock price fell by 74% over the last 12 months. This significant decline highlights challenges the company may be facing, potentially impacting investor confidence. The...

Market News
Bearish
4 hours ago
Shiba Inu's 42% on-chain activity rise isn't yet a bullish sign due to weak volume and resistance.

Shiba Inu's 42% on-chain activity rise isn't yet a bullish sign due to weak volume and resistance.

Shiba Inu's on-chain activity has increased by 42%, suggesting more transactions, but this has not yet translated into a bullish price trend. The token's price has stalled below a key resistance level around $0.0000056–$0.0000057, and momentum indica...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App